regenerative medicine
Internal Medicine

Liver Dysfunction Treatment Using Autologous Adipose-Derived Stem Cells【Saito Internal Medicine Clinic】

implementation facility

Facility Details

program name: Liver Dysfunction Treatment Using Autologous Adipose-Derived Stem Cells【Saito Internal Medicine Clinic】

genre

regenerative medicine：stem cell therapy
Internal Medicine：Internal Medicine

program details: Adipose-derived mesenchymal stem cells (MSCs) are isolated and cultured from the patient’s own adipose tissue. The cultured stem cells are then administered via intravenous infusion to promote liver function improvement.

Features
This therapy minimizes the risk of immune rejection by utilizing the patient’s own adipose tissue-derived MSCs.
As a form of regenerative medicine, it facilitates the repair and regeneration of damaged hepatocytes using stem cells.
Since the treatment is administered through intravenous infusion, it is a minimally invasive procedure with relatively low physical burden on the patient.
Procedure & Duration
Fat Tissue Collection: Performed under local anesthesia, the procedure takes approximately 30 minutes and can be completed in a single day.
Stem Cell Isolation & Culturing: The process of isolating and culturing stem cells from the collected fat tissue requires approximately 4 to 8 weeks.
Intravenous Administration: The infusion process takes approximately 1 to 2 hours and is conducted on an outpatient basis, eliminating the need for hospitalization.
Clinical Results
The application of adipose-derived MSC therapy has been extensively studied both domestically and internationally, with numerous reports supporting its safety and efficacy.
This therapy has been particularly beneficial for patients with liver dysfunction, including those who have not responded adequately to standard treatments.
Expected Benefits
Improvement in liver function markers, including ALT, AST, γ-GTP, and albumin (Alb) levels.
Reduction of symptoms such as fatigue and nausea, leading to an enhanced quality of life (QOL) for patients.
Considerations
Individual response to treatment may vary, and the total culture period and number of infusions are determined by the physician.
Regular follow-up assessments are required after treatment to monitor progress and ensure long-term safety.

requirement, condition for apply: Required Medical Information for Admission Assessment
- Referral Letter

remarks: 【Eligible Diseases & Conditions】
Liver Function Disorders
1. Patients diagnosed with liver function disorder by a physician.
2. Patients who have not achieved satisfactory results with standard treatment.

for more details information about this program,
kindly inquire from here

similar program available
in the same area